WO2023066834 - PYRROLIDINE DERIVATIVES AS DDRS INHIBITORS
National phase entry:
Publication Number
WO/2023/066834
Publication Date
27.04.2023
International Application No.
PCT/EP2022/078767
International Filing Date
17.10.2022
Title **
[English]
PYRROLIDINE DERIVATIVES AS DDRS INHIBITORS
[French]
DÉRIVÉS DE PYRROLIDINE EN TANT QU'INHIBITEURS DE DDR
Applicants **
CHIESI FARMACEUTICI S.P.A.
Inventors
CARZANIGA, Laura
RANCATI, Fabio
RIZZI, Andrea
GHIDINI, Eleonora
IOTTI, Nicolò
MAZZUCATO, Roberta
LEVANTO, Stefano
WHITTAKER, Ben Paul
Priority Data
21203367.4
19.10.2021
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2687 | |
| EPO | Filing, Examination, Granting | 12429 | |
| Japan | Filing, Examination, Granting | 2296 | |
| South Korea | Filing, Examination, Granting | 2283 | |
| USA | Filing, Examination, Granting | 5790 |
Total:
25,485
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to compounds of formula (I) inhibiting Discoidin Domain Receptors (DDR inhibitors), methods of preparing such compounds, intermediate compounds useful in such preparations, pharmaceutical compositions containing them and therapeutic use thereof. The compounds of the invention may be useful for instance in the treatment of many disorders associated with DDR mechanisms.[French]
La présente invention concerne des composés de formule (I) inhibant des récepteurs à domaine discoïdine (inhibiteurs de DDR), des procédés de préparation de tels composés, des composés intermédiaires utiles dans de telles préparations, des compositions pharmaceutiques les contenant et leur utilisation thérapeutique. Les composés de l'invention peuvent être utiles, par exemple, dans le traitement de nombreux troubles associés à des mécanismes DDR.